Skip to main content
Clinical Trials/DRKS00000473
DRKS00000473Active, not recruiting未知

An open label, randomized pilot study to evaluate diagnostic treatment interruption in HIV-positive children under a stable antiretroviral therapy in order to save medication and reduce possible side effects. - DARE

J.W. Goethe UniversitätZentrum für Kinder- und Jugendmedizin0 sites1 target enrollmentStarted: January 17, 2011Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Sponsor
Enrollment
1

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
3 Years to 11 Years (—)
Sex
All

Inclusion Criteria

  • Informed consent
  • Girls and Boys between 3 and 11 years
  • HIV infection under stable antiretroviral therapy based on a protease inhibitor
  • viral load <40cps
  • CD4 cells >30%
  • CDC classification N1 or A1
  • start of ART in first year of live, only because of age <12 months
  • participating in the ped. cohort of the competence network HIV/AIDS

Exclusion Criteria

  • co-infection
  • NNRTI-based antiretroviral therapy
  • non-adherence
  • condition that interferes with study participation according to the study physician

Investigators

Sponsor
J.W. Goethe UniversitätZentrum für Kinder- und Jugendmedizin

Similar Trials

An open label, randomized pilot study to... | Clinical Trial